$366 Million is the total value of DAFNA Capital Management LLC's 73 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 20.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Sell | SPDR S&P BIOTECH ETFetf | $47,008,000 | +8.2% | 565,000 | -0.9% | 12.85% | -1.3% |
| ISEE | IVERIC BIO INC | $24,114,437 | +61.7% | 612,975 | 0.0% | 6.59% | +47.5% | |
| STXS | STEREOTAXIS INC | $20,931,248 | -25.0% | 13,680,554 | 0.0% | 5.72% | -31.6% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $15,896,127 | +35.3% | 251,521 | -3.7% | 4.35% | +23.3% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $13,703,624 | +9.9% | 512,285 | -11.0% | 3.75% | +0.2% |
| IBB | ISHARES NASDAQ BIOTECH INDXetf | $13,013,400 | -1.7% | 102,500 | 0.0% | 3.56% | -10.4% | |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $12,067,671 | -16.8% | 135,212 | 0.0% | 3.30% | -24.1% | |
| MORF | Buy | MORPHIC HOLDING INC | $11,852,863 | +75.5% | 206,748 | +15.2% | 3.24% | +60.0% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $11,275,770 | +75.3% | 479,820 | +2.4% | 3.08% | +59.9% |
| CYTK | Buy | CYTOKINETICS INC | $10,853,783 | +11.6% | 332,734 | +20.3% | 2.97% | +1.7% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $10,800,713 | -4.5% | 280,538 | -11.2% | 2.95% | -12.9% |
| MRUS | Buy | MERUS N V | $10,133,627 | +93.9% | 384,870 | +35.5% | 2.77% | +76.8% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $9,436,772 | -0.1% | 450,873 | +0.8% | 2.58% | -8.9% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $9,145,215 | -35.9% | 42,173 | -46.3% | 2.50% | -41.6% |
| DXCM | DEXCOM INC | $8,681,108 | +10.6% | 67,552 | 0.0% | 2.37% | +0.9% | |
| SAGE | SAGE THERAPEUTICS INC | $8,477,988 | +12.1% | 180,306 | 0.0% | 2.32% | +2.2% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $7,036,195 | -6.8% | 74,615 | 0.0% | 1.92% | -15.0% | |
| ATRC | ATRICURE INC | $6,196,111 | +19.1% | 125,529 | 0.0% | 1.69% | +8.6% | |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $6,054,774 | – | 507,100 | +100.0% | 1.66% | – |
| Sell | DICE THERAPEUTICS INC | $5,927,599 | +10.3% | 127,585 | -32.0% | 1.62% | +0.6% | |
| NRIX | Sell | NURIX THERAPEUTICS INC | $5,561,383 | +10.5% | 556,695 | -1.8% | 1.52% | +0.8% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $5,499,288 | +13.6% | 611,032 | -0.8% | 1.50% | +3.6% |
| New | 2SEVENTY BIO INC | $5,023,730 | – | 496,416 | +100.0% | 1.37% | – | |
| VKTX | Sell | VIKING THERAPEUTICS INC | $4,760,148 | -10.4% | 293,655 | -8.0% | 1.30% | -18.3% |
| ARAY | ACCURAY INC | $4,730,525 | +30.3% | 1,222,358 | 0.0% | 1.29% | +18.8% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $4,584,312 | +43.4% | 225,717 | +28.8% | 1.25% | +30.8% |
| IPSC | CENTURY THERAPEUTICS INC | $4,131,406 | -8.9% | 1,307,407 | 0.0% | 1.13% | -16.9% | |
| EWTX | Sell | EDGEWISE THERAPEUTICS INC | $4,025,226 | -17.7% | 519,384 | -29.2% | 1.10% | -24.9% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $4,005,760 | -12.9% | 569,000 | +3.2% | 1.10% | -20.6% |
| ALEC | Buy | ALECTOR INC | $3,840,017 | +4.7% | 638,938 | +7.8% | 1.05% | -4.5% |
| KURA | Buy | KURA ONCOLOGY INC | $3,785,355 | +181.9% | 357,784 | +225.9% | 1.04% | +156.8% |
| New | ASCENDIS PHARMA A/Snote 2.250% 4/0 | $3,627,500 | – | 4,000,000 | +100.0% | 0.99% | – | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $3,421,511 | +25.0% | 94,700 | +28.7% | 0.94% | +14.1% |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $3,118,544 | +20.0% | 122,200 | 0.0% | 0.85% | +9.5% | |
| AXGN | AXOGEN INC | $3,032,100 | -3.4% | 332,103 | 0.0% | 0.83% | -11.9% | |
| MEDIWOUND LTD | $2,746,581 | -20.0% | 257,653 | 0.0% | 0.75% | -27.0% | ||
| TNDM | New | TANDEM DIABETES CARE INC | $2,699,400 | – | 110,000 | +100.0% | 0.74% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $2,667,680 | +27.1% | 810,845 | +58.7% | 0.73% | +15.7% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $2,214,338 | +2.3% | 930,394 | -20.9% | 0.60% | -6.8% |
| GLPG | GALAPAGOS NVspon adr | $2,141,766 | +5.2% | 52,675 | 0.0% | 0.59% | -3.9% | |
| ACET | ADICET BIO INC | $1,936,841 | -57.8% | 797,054 | 0.0% | 0.53% | -61.5% | |
| KROS | Buy | KEROS THERAPEUTICS INC | $1,915,019 | +131.6% | 47,661 | +146.2% | 0.52% | +111.3% |
| Buy | REGULUS THERAPEUTICS INC | $1,633,242 | +246.9% | 1,111,049 | +100.0% | 0.45% | +217.0% | |
| VIGIL NEUROSCIENCE INC | $1,619,695 | -4.0% | 172,308 | 0.0% | 0.44% | -12.5% | ||
| PRQR | PROQR THERAPEUTICS N V | $1,523,743 | -23.9% | 940,582 | 0.0% | 0.42% | -30.6% | |
| LYRA | New | LYRA THERAPEUTICS INC | $1,484,055 | – | 361,084 | +100.0% | 0.41% | – |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCspon ads | $1,331,897 | +71.8% | 1,009,013 | -8.0% | 0.36% | +56.9% |
| ITOS | ITEOS THERAPEUTICS INC | $1,304,934 | -2.7% | 98,560 | 0.0% | 0.36% | -11.2% | |
| BWAY | Buy | BRAINSWAY LTDsponsored ads | $1,150,673 | +38.3% | 504,681 | +6.5% | 0.32% | +26.5% |
| STRO | Buy | SUTRO BIOPHARMA INC | $1,128,922 | +188.5% | 242,779 | +186.6% | 0.31% | +164.1% |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $1,096,667 | +2.2% | 350,373 | +47.9% | 0.30% | -6.8% |
| Buy | ASTRIA THERAPEUTICS INC | $1,063,349 | +14.4% | 127,653 | +82.7% | 0.29% | +4.3% | |
| Buy | ACRIVON THERAPEUTICS INC | $996,002 | +53.5% | 76,852 | +50.3% | 0.27% | +39.5% | |
| SURF | SURFACE ONCOLOGY INC | $956,560 | +24.4% | 1,100,000 | 0.0% | 0.26% | +13.9% | |
| SYROS PHARMACEUTICALS INC | $837,516 | +18.0% | 265,878 | 0.0% | 0.23% | +7.5% | ||
| Sell | PARDES BIOSCIENCES INC | $778,827 | +23.1% | 430,291 | -10.2% | 0.21% | +12.1% | |
| NVRO | New | NEVRO CORP | $711,760 | – | 28,000 | +100.0% | 0.20% | – |
| ELEV | New | ELEVATION ONCOLOGY INC | $684,000 | – | 450,000 | +100.0% | 0.19% | – |
| STIM | NEURONETICS INC | $674,492 | -26.1% | 313,717 | 0.0% | 0.18% | -32.8% | |
| SPRB | SPRUCE BIOSCIENCES INC | $670,800 | -2.7% | 312,000 | 0.0% | 0.18% | -11.6% | |
| Sell | BIOHAVEN LTD | $505,023 | -84.3% | 21,113 | -91.0% | 0.14% | -85.7% | |
| MASI | MASIMO CORP | $493,650 | -10.8% | 3,000 | 0.0% | 0.14% | -18.7% | |
| CMPX | COMPASS THERAPEUTICS INC | $371,685 | -2.8% | 116,882 | 0.0% | 0.10% | -11.3% | |
| KPTI | KARYOPHARM THERAPEUTICS INC | $344,894 | -54.0% | 192,678 | 0.0% | 0.09% | -58.2% | |
| NXTC | NEXTCURE INC | $337,853 | +21.6% | 187,696 | 0.0% | 0.09% | +10.8% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $324,734 | -15.1% | 351,064 | 0.0% | 0.09% | -22.6% | |
| MDNA | MEDICENNA THERAPEUTICS CORP | $317,922 | -23.5% | 660,000 | 0.0% | 0.09% | -30.4% | |
| New | PROCEPT BIOROBOTICS CORP | $282,800 | – | 8,000 | +100.0% | 0.08% | – | |
| KNTE | Sell | KINNATE BIOPHARMA INC | $242,942 | -52.0% | 80,179 | -1.0% | 0.07% | -56.6% |
| CGEN | COMPUGEN LTDord | $233,930 | +62.4% | 205,202 | 0.0% | 0.06% | +48.8% | |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $197,400 | -6.0% | 140,000 | 0.0% | 0.05% | -14.3% | |
| SPRO | SPERO THERAPEUTICS INC | $181,250 | 0.0% | 125,000 | 0.0% | 0.05% | -7.4% | |
| INGN | INOGEN INC | $173,250 | -7.5% | 15,000 | 0.0% | 0.05% | -16.1% | |
| Exit | REUNION NEUROSCIENCE INC | $0 | – | -12,598 | -100.0% | -0.00% | – | |
| IKNA | Exit | IKENA ONCOLOGY INC | $0 | – | -112,936 | -100.0% | -0.12% | – |
| GNFT | Exit | GENFIT S Aads | $0 | – | -197,940 | -100.0% | -0.24% | – |
| ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -170,326 | -100.0% | -0.29% | – |
| Exit | THESEUS PHARMACEUTICALS INC | $0 | – | -131,025 | -100.0% | -0.35% | – | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -57,746 | -100.0% | -1.14% | – |
| CSII | Exit | CARDIOVASCULAR SYSTEMS | $0 | – | -286,988 | -100.0% | -1.71% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 41 | Q2 2023 | 27.6% |
| ATRICURE INC | 41 | Q2 2023 | 11.4% |
| MASIMO CORPORATION | 41 | Q2 2023 | 1.8% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| ASCENDIS PHARMA A S SPONSORED | 33 | Q2 2023 | 4.5% |
| GALAPAGOS NV-SPON ADR | 32 | Q2 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 32 | Q2 2023 | 3.6% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q2 2023 | 2.9% |
| BIOTELEMETRY INC | 30 | Q4 2020 | 3.3% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ENCISION INC | February 14, 2023 | 964,662 | 8.2% |
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.